Neutrophil to lymphocyte ratio and risk of neoplastic progression in patients with Barrett’s ...

Neutrophil to lymphocyte ratio and risk of neoplastic progression in patients with Barrett’s ...

Noam Peleg on " Neutrophil to lymphocyte ratio and risk of neoplastic progression in patients with Barrett’s esophagus"

Authors: Noam Peleg, Hemda Schmilovitz-Weiss, Steven Shamah et al.
Summary:
An analysis in 324 individuals with Barrett’s esophagus showed that a simple inflammation marker, the peripheral blood neutrophil to lymphocyte ratio (NLR), was predictive of progression to neoplasia. In particular, an NLR above 2.4 was associated with a 3-fold increase in progression to high grade dysplasia or adenocarcinoma during follow-up. This finding was consistent even in patients with nondysplastic
Barrett’s esophagus at baseline.

Bibliography
Endoscopy 2021; 53: 774–781
DOI 10.1055/a-1292-8747
ISSN 0013-726X
© 2020. Thieme. All rights reserved.
Georg Thieme Verlag KG, Rüdigerstraße 14,
70469 Stuttgart, Germany

Read more here: https://doi.org/10.1055/a-1292-8747

barrrettesophagusinflammation

Post a Comment

0 Comments